318 related articles for article (PubMed ID: 17936845)
1. Biomarkers for prostate cancer detection.
Parekh DJ; Ankerst DP; Troyer D; Srivastava S; Thompson IM
J Urol; 2007 Dec; 178(6):2252-9. PubMed ID: 17936845
[TBL] [Abstract][Full Text] [Related]
2. New circulating biomarkers for prostate cancer.
Bensalah K; Lotan Y; Karam JA; Shariat SF
Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918
[TBL] [Abstract][Full Text] [Related]
3. Serum markers for prostate cancer: a rational approach to the literature.
Steuber T; O'Brien MF; Lilja H
Eur Urol; 2008 Jul; 54(1):31-40. PubMed ID: 18243505
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers of prostate cancer.
Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
[TBL] [Abstract][Full Text] [Related]
5. Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes.
Flaig TW; Nordeen SK; Lucia MS; Harrison GS; Glodé LM
J Urol; 2007 Apr; 177(4):1229-37. PubMed ID: 17382696
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
Sardana G; Jung K; Stephan C; Diamandis EP
J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.
Hernández J; Thompson IM
Cancer; 2004 Sep; 101(5):894-904. PubMed ID: 15329895
[TBL] [Abstract][Full Text] [Related]
8. Blood biomarkers for prostate cancer detection and prognosis.
Shariat SF; Karam JA; Roehrborn CG
Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720
[TBL] [Abstract][Full Text] [Related]
9. Other biomarkers for detecting prostate cancer.
Nogueira L; Corradi R; Eastham JA
BJU Int; 2010 Jan; 105(2):166-9. PubMed ID: 19930175
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for prostate cancer detection.
Reed AB; Parekh DJ
Expert Rev Anticancer Ther; 2010 Jan; 10(1):103-14. PubMed ID: 20014890
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for prostate cancer.
Makarov DV; Loeb S; Getzenberg RH; Partin AW
Annu Rev Med; 2009; 60():139-51. PubMed ID: 18947298
[TBL] [Abstract][Full Text] [Related]
12. Beyond prostate-specific antigen: alternate serum markers.
Ramírez ML; Nelson EC; Evans CP
Prostate Cancer Prostatic Dis; 2008; 11(3):216-29. PubMed ID: 18227856
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for prostate cancer.
Leman ES; Getzenberg RH
J Cell Biochem; 2009 Sep; 108(1):3-9. PubMed ID: 19507229
[TBL] [Abstract][Full Text] [Related]
14. [Markers for diagnosis, prediction and prognosis of prostate cancer].
Taskén KA; Angelsen A; Svindland A; Eide T; Berge V; Wahlquist R; Karlsen S
Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3279-82. PubMed ID: 16327854
[TBL] [Abstract][Full Text] [Related]
15. [Biomarkers for prostate cancer in predicting diagnosis, staging and prognosis].
Ohori M
Gan To Kagaku Ryoho; 2009 Jan; 36(1):6-10. PubMed ID: 19151558
[TBL] [Abstract][Full Text] [Related]
16. Proteomics for the identification of new prostate cancer biomarkers.
Ornstein DK; Tyson DR
Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
[TBL] [Abstract][Full Text] [Related]
17. Proteomics in prostate cancer biomarker discovery.
Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
[TBL] [Abstract][Full Text] [Related]
18. Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.
Jansen FH; Roobol M; Jenster G; Schröder FH; Bangma CH
Eur Urol; 2009 Mar; 55(3):563-74. PubMed ID: 19058905
[TBL] [Abstract][Full Text] [Related]
19. Combining biomarkers to detect disease with application to prostate cancer.
Etzioni R; Kooperberg C; Pepe M; Smith R; Gann PH
Biostatistics; 2003 Oct; 4(4):523-38. PubMed ID: 14557109
[TBL] [Abstract][Full Text] [Related]
20. Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection.
Schostak M; Schwall GP; Poznanović S; Groebe K; Müller M; Messinger D; Miller K; Krause H; Pelzer A; Horninger W; Klocker H; Hennenlotter J; Feyerabend S; Stenzl A; Schrattenholz A
J Urol; 2009 Jan; 181(1):343-53. PubMed ID: 19012935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]